Onto Innovation ( ONTO ) announced the pricing of a private offering of $1.3B in aggregate principal amount of 0.00% convertible senior notes due 2031 to investors believed to be qualified institutional buyers. The notes will have an initial conversion price of ~$381.80 per share of Onto Innovation’s common stock, which represents a premium of ~50.0% to the last reported sale price of Onto Innovat...
Onto Innovation ( ONTO ) announced the pricing of a private offering of $1.3B in aggregate principal amount of 0.00% convertible senior notes due 2031 to investors believed to be qualified institutional buyers. The notes will have an initial conversion price of ~$381.80 per share of Onto Innovation’s common stock, which represents a premium of ~50.0% to the last reported sale price of Onto Innovation’s common stock on NYSE on May 18. The size of the offering was increased from the previously announced $1,100,000,000 aggregate principal amount of notes. Onto Innovation estimates that the net proceeds from the offering will be approximately $1,274 million. More on Onto Innovation Onto Innovation Inc. (ONTO) Q1 2026 Earnings Call Transcript Why Onto Innovation Is A Still A Buy After More Than Doubling In 4 Years Onto Innovation: Why The Risk Is To The Downside Onto Innovation to offer $1.1B convertible senior notes Onto Innovation expects 2026 revenue growth of more than 30% while targeting Q4 operating margin greater than 30%
(RTTNews) - Allegiant Travel Co. (ALGT) on Tuesday said it has added eight new nonstop routes to its Allegiant Air network, expanding its presence in key leisure destinations across Florida. To promote the new routes, the airline is also offering limited-time one-way fares starti
(RTTNews) - Allegiant Travel Co. (ALGT) on Tuesday said it has added eight new nonstop routes to its Allegiant Air network, expanding its presence in key leisure destinations across Florida. To promote the new routes, the airline is also offering limited-time one-way fares starti
Insight with Haslinda Amin, a daily news program featuring in-depth, high-profile interviews and analysis to give viewers the complete picture on the stories that matter. The show features prominent leaders spanning the worlds of business, finance, politics and culture. (Source: Bloomberg)
Insight with Haslinda Amin, a daily news program featuring in-depth, high-profile interviews and analysis to give viewers the complete picture on the stories that matter. The show features prominent leaders spanning the worlds of business, finance, politics and culture. (Source: Bloomberg)
Alphabet’s Google agreed to create an artificial intelligence cloud business with Blackstone, aiming to compete with companies like CoreWeave in a burgeoning market. The project will rely on an initial $5 billion in equity capital from Blackstone, which will become the majority owner, according to a statement Monday. Bloomberg's Neil Campling explains. (Source: Bloomberg)
Alphabet’s Google agreed to create an artificial intelligence cloud business with Blackstone, aiming to compete with companies like CoreWeave in a burgeoning market. The project will rely on an initial $5 billion in equity capital from Blackstone, which will become the majority owner, according to a statement Monday. Bloomberg's Neil Campling explains. (Source: Bloomberg)
(RTTNews) - Blackstone (BX) announced a joint venture with Google to create a new U.S.-based company that will offer efficient data center capacity, operations, networking, and Google Cloud's Tensor Processing Units as a compute-as-a-service offering. Google's TPUs are custom chi
(RTTNews) - Blackstone (BX) announced a joint venture with Google to create a new U.S.-based company that will offer efficient data center capacity, operations, networking, and Google Cloud's Tensor Processing Units as a compute-as-a-service offering. Google's TPUs are custom chi
claffra/iStock via Getty Images DHT Holdings ( DHT ) has been on a tear YTD, up nearly 50%. The company has benefitted from tighter crude oil supply and demand dynamics, which have forced spot rates up for the company's transportation ships, VLCCs. The company seems to be firing on all cylinders, and there are real reasons why the stock can continue to work in the near term, but my concern rests w...
claffra/iStock via Getty Images DHT Holdings ( DHT ) has been on a tear YTD, up nearly 50%. The company has benefitted from tighter crude oil supply and demand dynamics, which have forced spot rates up for the company's transportation ships, VLCCs. The company seems to be firing on all cylinders, and there are real reasons why the stock can continue to work in the near term, but my concern rests with the fragility of global oil markets and the need for the conflict in the Middle East to end in relatively short order. While the company has an impressive 14.5% dividend yield, so there is a rather large buffer against downside risk, this dividend payout will shrink if the conflict resolves. I view its fundamentals as more akin to that of a defense company right now, but because of the sizable yield, I am starting coverage with a hold. Business Profile DHT is an independent crude oil tanker company. This means that the company owns a fleet of transportation ships in the VLCC segment - very large crude carriers. These are ships that are quite literally designed to carry tremendous amounts of crude oil over long distances. Some of them can carry up to 2 million barrels of oil and measure over 1,100 feet long. The company primarily earns chartering rates for its VLCCs and collects that as revenue. Generally speaking, it is reliant on global volume growth in crude oil in order to have robust results, but pricing can also help that equation as it indirectly pushes up the prices for carriers. As of the end of last quarter, the company had a fleet of 23 VLCCs with a weight of 7.16 million DWT - that is dead weight tons. The company had three newbuildings delivered during Q1: the DHT Antelope, Addax, and Gazelle. This is all while the company sold DHT China and DHT Europe during the quarter. Also, the company sold DHT Bauhinia for $51.5 million and had a capital gain on it of $34.2 million, and this will be delivered to their customer this summer. For VLCC, the market is curren...
Rapid Micro Biosystems ( RPID ) has announced the pricing for its underwritten offering , which includes 3.58M shares of Class A common stock and accompanying Series A and Series B warrants. These warrants allow the purchase of additional shares of Class A common stock. Some common stock will be replaced with pre-funded warrants for certain investors. The total shares and warrants being offered al...
Rapid Micro Biosystems ( RPID ) has announced the pricing for its underwritten offering , which includes 3.58M shares of Class A common stock and accompanying Series A and Series B warrants. These warrants allow the purchase of additional shares of Class A common stock. Some common stock will be replaced with pre-funded warrants for certain investors. The total shares and warrants being offered also involve 1.46M shares and related warrants sold to specific investors. The Series A warrants have an exercise price of $1.955 per share and expire one year after issuance. The Series B warrants have an exercise price of $2.34 per share and expire five years after issuance. The combined offering price for each share of Class A common stock with accompanying warrants is $1.955, while the combined price for each pre-funded warrant is $1.945. The offering includes participation from Bain Capital Life Sciences and Armistice Capital LLC. In addition to the main offering, Rapid Micro Biosystems has a separate agreement with certain officers and directors to sell 71,607 shares of Class A common stock along with warrants at the same pricing conditions. The total gross proceeds from both the main offering and the additional agreement are estimated to be around $9.8 million, with potential additional funds from exercising the warrants amounting to $21.7 million. The whole offering is expected to close on May 20, 2026, pending usual closing conditions. More on Rapid Micro Biosystems Rapid Micro Biosystems, Inc. (RPID) Q1 2026 Earnings Call Transcript Rapid Micro Biosystems: Big Pharma Adoption Driving Growth Rapid Micro Biosystems, Inc. (RPID) Q4 2025 Earnings Call Transcript Rapid Micro Biosystems outlines $37M–$41M 2026 revenue target amid record system placements and margin expansion drive Rapid Micro Biosystems reports mixed Q4 results; introduces FY26 outlook
JHVEPhoto/iStock Editorial via Getty Images In this article I will outline my bullish thesis for Eli Lilly and Company ( LLY ). I will use my technical analysis approach, which consists of price action, momentum, volume, and relative strength. I will also comment on its current valuation grade, and I will comment on its most recent earnings report. My guess is that most Seeking Alpha readers are f...
JHVEPhoto/iStock Editorial via Getty Images In this article I will outline my bullish thesis for Eli Lilly and Company ( LLY ). I will use my technical analysis approach, which consists of price action, momentum, volume, and relative strength. I will also comment on its current valuation grade, and I will comment on its most recent earnings report. My guess is that most Seeking Alpha readers are familiar with the pharmaceutical giant Eli Lilly. They are based out of Indiana, and they are known for Humulin, Jardiance, and Trulicity, among other products. Valuation Many investors are concerned about the valuation of a company of which they want to purchase shares. That makes sense, as no one wants to overpay for a company. It's hard to make money buying stocks if you overpay. However, I am not a believer in the standard valuation metrics that are often used. Actually, I am not a fundamentally schooled investor. I prefer the technical analysis approach to analyzing stocks, as I will outline later in this article. Here is why I'm hesitant to focus too much on standard valuation metrics. Figure 1: Seeking Alpha Factor Grades for LLY Factor Grades for LLY(Seeking Alpha) Figure 1 above shows LLY with an "F" grade for valuation. That grade would scare away many fundamentally schooled investors. They would be walking away from a company that is excelling in growth and profitability. The stock also has a high grade for revisions, meaning the Wall Street firms are revising their earnings and revenue forecasts for LLY higher. Any shareholder wants to believe that future earnings and revenues will be higher than expected. Because I am focused on technical analysis, I use different metrics to conclude that LLY is not overvalued at the current price. I often find myself investing in companies that have an "F" valuation grade, and I wrote about two of them here and here . Recent Earnings Announcement Lilly announced earnings on April 30th. They announced quarterly earnings of $8.55...
(RTTNews) - European stocks are likely to open higher on Tuesday as oil prices fell from two-week highs amid hopes of a de-escalation in the West Asia conflict.
(RTTNews) - European stocks are likely to open higher on Tuesday as oil prices fell from two-week highs amid hopes of a de-escalation in the West Asia conflict.